Aplaviroc

Tags: Drug.

Aplaviroc (INN codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor developed for the treatment of HIV infection. It is developed by GlaxoSmithKline.In October 2005 all studies of aplaviroc were discontinued due to liver toxicity concerns.

thumbnail

ATC prefix

none

CAS number

461023-63-2

FDA UNII code

98B425P30V

IUPAC name

4-(4-[(3R)-1-butyl-3-[(R)-cyclohexylhydroxymethyl]-25-dioxo- 149-triazaspiro[5.5]undecan-9-yl]methylphenoxy)benzoic acid

PubChem

3001322